Home

SAiGENCI logo

SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.

Help make cancer history

100% of your gift will support leading-edge cancer research, which will lead to better outcomes for patients with cancer, and their families.

With your support, we can save lives.

Give now

Featured projects

Towards the future: improving survivorship for children with brain cancer

Brain cancer is the most common solid tumour of childhood and most lethal type of cancer in Australian children.

Read more about improving survivorship for children with brain cancer

Unlocking the mysteries of prostate cancer

The SAiGENCI team is creating a comprehensive data repository and applying machine learning to uncover revolutionary insights for prostate cancer treatment and prevention.

Read more about Unlocking the mysteries of prostate cancer

Leadership appointments

Professor Christopher Sweeney

Professor Christopher Sweeney is SAiGENCI's inaugural Director.

Read more

Professor Jose Polo

Professor Jose Polo has been appointed Program Lead for Cancer Epigenetics in SAiGENCI to build the epigenetics capacity within the Institute.  Professor Polo will establish the Adelaide Centre for Epigenetics (ACE). 

Read more

Professor Brendan Jenkins

Professor Brendan Jenkins joins SAiGENCI as Program Lead, Tumour Inflammation and Immunotherapy.

Read more

Scientific appointments

Dr Stefano Mangiola

Dr Stefano Mangiola is a Group Leader at SAiGENCI and a VCA Fellow in computational cancer immunology.  He leads the Computational Cancer Immunogenomics laboratory at SAiGENCI in the Resistance Prevention program.

Read more

Dr Qi Zhang

Dr Qi Zhang is SAiGENCI's first EMBL Australia Group Leader in the Cancer Epigenetics program.

Read more

Dr Fuyi Li

Dr Fuyi Li is establishing a research group focusing on developing Artificial Intelligence and Machine Learning approaches for cancer research as a Group Leader in the Computational Systems Oncology program.

Read more

Dr Yannan Yang

Dr Yannan Yang is Group Leader, Biomaterials and Immune Engineering Laboratory (BIEL) within the Tumour Inflammation and Immunotherapy program.

Read more

Dr Luke Isbel

Dr Luke Isbel holds a joint Group Leader appointment within the South Australian immunoGENomics Cancer Institute (SAiGENCI) and the Adelaide Centre for Epigenetics (ACE), where he will focus on the role of chromatin in development and in disease states like cancer.

Read more

Dr Adrienne Sullivan

Dr Adrienne Sullivan holds a Group Leader joint appointment with the Adelaide Centre for Epigenetics (ACE) and SAiGENCI as Head of Development and Epigenetics Laboratory with ACE and SAiGENCI's Cancer Epigenetics program.

Read more

Professor Lisa Butler

Professor Lisa Butler has been appointed Lead SAiGENCI Associate in SAHMRI, and Prostate Cancer Theme Lead in the Hormone Dependent Cancers Program. She will also lead SAiGENCI’s Graduate Program for HDR and Honours students.

Read more

Associate Professor Luciano Martelotto

Associate Professor Luciano Martelotto has been appointed to establish a Single Cell and Spatial Technologies Lab for SAiGENCI.

Read more

News

21

Feb

SAiGENCI Hosts Summer Student Researchers

Over the 2023-24 summer, the South Australian immunoGENomics Cancer Institute (SAiGENCI) welcomed five Adelaide Summer Research Scholarship recipients.  Each of the University of Adelaide undergraduate students spent six weeks working side-by-side with SAiGENCI researchers gaining valuable hands-on research experience and an insight into a career in science.

16

Feb

Team SAiGENCI at Lorne Genome 2024

Visually celebrating our charismatic cohort of young leaders as they trailblaze through the breathtaking beach-side conference Lorne Genome 2024 – Australia’s premier genome conference!  Congratulations to Dr Luke Isbel for the prestigious Lorne Genome Mid-Career Award, and a round of applause for Dr Adrienne Sullivan and Dr Qi Zhang for their stellar representation of SAiGENCI while out and about!

more...

Events

15

Feb

The Adelaide Cancer Seminar Series

The Adelaide Cancer Seminar Series are jointly organised by the South Australian immunoGENomics Cancer Institute (SAiGENCI), Centre for Cancer Biology (CCB) and the South Australian Health and Medical Research Institute (SAHMRI).  The aim of the seminar series is to forge links across the research community, foster collaborative links between the researchers within Australia and internationally and to showcase outstanding research being conducted around Australia by top scientists.

more...

Updates from Twitter

Follow us on Twitter for the latest from SAiGENCI.

SAiGENCI on Twitter